CD44 antibody (FITC)
Quick Overview for CD44 antibody (FITC) (ABIN2853597)
Target
See all CD44 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- This antibody reacts with CD44 antigen.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Protein A agarose beads
-
Immunogen
- MML-1 human leukemia cells
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.05 mg/mL
-
Buffer
- PBS, 0.09 % NaN3, 1 % BSA
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8 °C.
-
-
- CD44
-
Alternative Name
- CD44
-
Background
- CD44, also known as H-CAM, Homing Cell Adhesion Molecule, and Pgp-1 is a highly glycosylated transmembrane protein expressed by lymphocytes, fibroblasts, smooth muscle cells, and epithelial cells. CD44 functions as lymphocyte adhesion molecule, acting as a matrix receptor that mediates cell adhesion to the extracellular matrix. CD44 is also involved in T-lymphocyte activation, lymphocyte homing, cell migration, and hematopoiesis. Expression of CD44 on the cell surface changes profoundly during tumor metastasis, and the transition from non-metastatic to metastatic tumor cell variants is associated with expression of CD44 variants (CD44v's), making CD44 a potential cancer marker. CD44 has a predicted molecular weight of 85-90 kDa, but glycosylation can increase the apparent MW to ~200 kDa.Synonyms: CDw44, ECMR-III, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, LHR, MDU2, MDU3, MIC4, PGP-1, Phagocytic glycoprotein 1
-
Gene ID
- 960
-
NCBI Accession
- NP_000601
-
UniProt
- P16070
-
Pathways
- Glycosaminoglycan Metabolic Process, Autophagy, Negative Regulation of intrinsic apoptotic Signaling
Target
-